Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports.

JCO Oncol Pract

Todd C. Knepper, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL; Theresa A. Boyle, MD, PhD, Molecular Pathology, Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL; J. Kevin Hicks PhD, PharmD and Christine M. Walko, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.

Published: August 2023

Download full-text PDF

Source
http://dx.doi.org/10.1200/OP.23.00216DOI Listing

Publication Analysis

Top Keywords

pharmacist-driven precision
4
precision medicine
4
medicine ferry
4
ferry cross
4
cross chasm
4
chasm interpreting
4
interpreting biomarker
4
biomarker testing
4
testing reports
4
pharmacist-driven
1

Similar Publications

Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports.

JCO Oncol Pract

August 2023

Todd C. Knepper, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL; Theresa A. Boyle, MD, PhD, Molecular Pathology, Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL; J. Kevin Hicks PhD, PharmD and Christine M. Walko, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.

View Article and Find Full Text PDF

Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly.

J Am Geriatr Soc

November 2022

Office of Translational Research and Residency Programs (OTRRP), Tabula Rasa HealthCare, Inc., Moorestown, New Jersey, USA.

Background: Given associations with serious cognitive and physical adverse effects (e.g., dementia, falls), strong anticholinergics, like urinary antimuscarinics (UAMs), should be avoided in older adults.

View Article and Find Full Text PDF

Impact of an Oral Antineoplastic Renewal Clinic on Medication Possession Ratio and Cost-Savings.

Fed Pract

March 2021

and are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.

Purpose: The primary objective of this study was to evaluate the impact of a pharmacist-driven oral antineoplastic (OAN) renewal clinic on medication adherence and cost savings.

Methods: This was a preimplementation and postimplementation retrospective cohort evaluation within a single US Department of Veterans Affairs health care system following implementation of a pharmacist-managed OAN refill clinic. The primary outcome was medication adherence defined as the median medication possession ratio (MPR) before and after implementation of the clinic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!